Defibrillator drones? A potential method of reducing response time in OHCA
By Ahmed El-Medany A prospective pilot study by Schierbeck et al (2021), presented at ESC 2021, investigated the practicality of drone-delivered automatic external defibrillators (AEDs)…
View More Defibrillator drones? A potential method of reducing response time in OHCA
Polypill beats monotherapy for hypertension: results from the QUARTET stud
By Ahmed El-Medany Treatment with a ‘quadpill’ containing quarter doses of four antihypertensive drugs demonstrated better blood pressure control than initial monotherapy with full-dose irbesartan,…
View More Polypill beats monotherapy for hypertension: results from the QUARTET stud
RCP release statement on COVID-19 vaccination for the severely immunosuppressed
On the 13th of September the Royal College of Physicians (RCP) released a statement regarding vaccination in the severely immunocompromised, in response to the Joint…
View More RCP release statement on COVID-19 vaccination for the severely immunosuppressed
Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.
92 senior representatives of the Inequalities in Health Alliance (IHA) have written to the Prime Minister calling for a cross-government strategy to reduce health inequalities. The letter…
View More Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.
Danger: High levels of hospital bed occupancy rates in England
Taken directly from BMJ news Overall, 83.8% of the 123 707 beds available overnight were occupied between April and June this year, show bed occupancy rates…
View More Danger: High levels of hospital bed occupancy rates in England
Reducing barriers to MRI in patients with CIEDs
Taken directly from European Heart Journal Many cardiac pacemakers and defibrillators are not approved by regulators for magnetic resonance imaging (MRI) which makes patient access…
View More Reducing barriers to MRI in patients with CIEDs
Percutaneous Coronary Revascularisation: Historical Breakthroughs
Taken directly from JACC Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with…
View More Percutaneous Coronary Revascularisation: Historical Breakthroughs
Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic
A Consensus StatementTaken directly from JAMA Network Open Question What leadership imperatives are most essential for health leaders following the emergency stages of the COVID-19…
View More Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic
Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…
View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF
The ENVISAGE-TAVI AF trial demonstrated that Edoxaban’s non-inferiority to warfarin with regards to myocardial infarction (MI), ischaemic stroke, systemic thromboembolism, and valve thrombosis, in participants…
View More Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF